New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Grenoble
About this trial
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
Eligibility criteria
Qualifiers
Being a trans masculine individual
Taking a gender affirming hormonal therapy (GAHT)
living close to Grenoble
having pelvic pain that appeared or were modified after taking GAHT
Disqualifiers
Subject under guardianship or subject deprived of liberty Refusal of voice recording
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1UGA38100, Saint-Martin-d'Hères France
Sponsors and collaborators
University Hospital, Grenoble
Lead sponsor
Source ClinicalTrials.gov